NCT00849251 Pegylated Liposomal Doxorubicin Hydrochloride, Bortezomib, Cyclophosphamide, and Dexamethasone in Treating Patients With Multiple Myeloma Status TERMINATED Phase PHASE1/PHASE2
NCT00843310 Combination of Revlimid, Melphalan and Dexamethasone as First Line Treatment for Multiple Myeloma Status TERMINATED Phase PHASE2
NCT00835965 Oral Aprepitant and Lower Dose Dexamethasone Versus Aprepitant Alone for Preventing Postoperative Nausea and Vomiting (PONV) After Elective Laparoscopic Surgeries Status UNKNOWN Phase NA
NCT00833833 MTD, Safety, and Efficacy of Pomalidomide (CC-4047) Alone or With Low-dose Dexamethasone in Patients With Relapsed and Refractory Multiple Myeloma Status COMPLETED Phase PHASE1/PHASE2
NCT00833560 A Study of Bortezomib, Cyclophosphamide, and Dexamethasone in Patients With Untreated Multiple Myeloma and Planned for a High Dose Chemotherapy Status COMPLETED Phase PHASE2
NCT00832338 Trial Using Docetaxel Cytoxan in Breast Cancers With High Recurrence Scores Status TERMINATED Phase PHASE2
NCT00818259 A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134) Status TERMINATED Phase PHASE1
NCT00813150 Study of Bortezomib and Dexamethasone With or Without Cyclophosphamide in Patients With Relapsed or Not Controllable Multiple Myeloma Status COMPLETED Phase PHASE3
NCT00805649 Combined Therapy in Age-Related Macular Degeneration (ARMD) Status COMPLETED Phase PHASE4
NCT00802009 Dexamethasone and Analgesic Duration After Supraclavicular Brachial Plexus Blockade Status COMPLETED Phase NA
NCT00801138 The Effect of Dexamethasone on the Duration of Interscalene Nerve Blocks With Ropivacaine or Bupivacaine Status TERMINATED Phase NA
NCT00799227 Safety and Efficacy of a New Treatment in Vitrectomized Subjects With Diabetic Macular Edema Status COMPLETED Phase PHASE2
NCT00793663 Depth of Hypnosis and Postoperative Nausea and Vomiting During Xenon Anaesthesia Status COMPLETED Phase PHASE4
NCT00792948 Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT00792142 Bortezomib, Thalidomide, and Dexamethasone After Melphalan and Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma Status COMPLETED Phase PHASE2
NCT00790842 Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction Status TERMINATED Phase PHASE1/PHASE2